Novel role of inflammasome activation in ART neurotoxicity

炎症小体激活在 ART 神经毒性中的新作用

基本信息

  • 批准号:
    9925422
  • 负责人:
  • 金额:
    $ 23.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-05-12 至 2022-02-28
  • 项目状态:
    已结题

项目摘要

ABSTRACT Toxicity of ART contributes to brain pathology and cognitive decline observed in HIV-infected individuals; however, the mechanisms are not fully understood. The importance of ART toxicity has been further enhanced by the introduction of pre-exposure prophylaxis (PrEP) into HIV prevention. The blood-brain barrier (BBB) is on the first line of exposure to antiretroviral drugs, making the brain endothelium particularly relevant in studies on toxicity of ART. While antiretroviral drugs frequently achieve only sub-therapeutic levels in the brain parenchyma, their plasma concertations are sufficient to negatively impact the brain vasculature, making the brain endothelium the main target of ART toxicity in the CNS. The current application is based on our exciting findings indicating that ART exposure results in mitochondrial dysfunction and alterations of neurogenesis of neural progenitor cells (NPCs). Mitochondrial dysregulation is a strong inducer of inflammasome, and indeed, our results implicate inflammasome activation in ART-induced cerebral vascular toxicity. Mechanistically, the proposed work is focused on a novel pathway of intercellular communication between the brain endothelium and perivascular NPCs via activation of inflammasome. The central hypothesis is that ART activates inflammasome in brain endothelial cells, followed by release of IL1β, which then affects adult neurogenesis of NPCs, diminishing their differentiation into mature neurons and contributing to cognitive decline. Throughout the proposal, we will differentiate the impact of ART with high CNS penetrating efficacy (CPE) vs. ART with low CPE. Our application offers a unique, mechanistic, and translational perspective on ART-induced toxicity and neuroinflammation that results in cognitive impairment. The completion of the proposed study promises to establish new therapeutic targets to protect against toxicity of ART.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michal Toborek其他文献

Michal Toborek的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michal Toborek', 18)}}的其他基金

Cerebral vascular pathology of COVID-19
COVID-19 的脑血管病理学
  • 批准号:
    10553944
  • 财政年份:
    2022
  • 资助金额:
    $ 23.03万
  • 项目类别:
Defining brain pericytes as a novel and myeloid-derived HIV reservoir
将大脑周细胞定义为一种新型的、源自骨髓的 HIV 储存库
  • 批准号:
    10432128
  • 财政年份:
    2021
  • 资助金额:
    $ 23.03万
  • 项目类别:
Defining brain pericytes as a novel and myeloid-derived HIV reservoir
将大脑周细胞定义为一种新型的、源自骨髓的 HIV 储存库
  • 批准号:
    10327440
  • 财政年份:
    2021
  • 资助金额:
    $ 23.03万
  • 项目类别:
Defining brain pericytes as a novel and myeloid-derived HIV reservoir
将大脑周细胞定义为一种新型的、源自骨髓的 HIV 储存库
  • 批准号:
    10612454
  • 财政年份:
    2021
  • 资助金额:
    $ 23.03万
  • 项目类别:
Targeting Inflammasomes in Substance Abuse and HIV
针对药物滥用和艾滋病毒中的炎症小体
  • 批准号:
    10645136
  • 财政年份:
    2020
  • 资助金额:
    $ 23.03万
  • 项目类别:
Novel role of inflammasome activation in ART neurotoxicity
炎症小体激活在 ART 神经毒性中的新作用
  • 批准号:
    10163270
  • 财政年份:
    2020
  • 资助金额:
    $ 23.03万
  • 项目类别:
Targeting Inflammasomes in Substance Abuse and HIV
针对药物滥用和艾滋病毒中的炎症小体
  • 批准号:
    10371747
  • 财政年份:
    2020
  • 资助金额:
    $ 23.03万
  • 项目类别:
Targeting Inflammasomes in Substance Abuse and HIV
针对药物滥用和艾滋病毒中的炎症小体
  • 批准号:
    10622305
  • 财政年份:
    2020
  • 资助金额:
    $ 23.03万
  • 项目类别:
Targeting Inflammasomes in Substance Abuse and HIV
针对药物滥用和艾滋病毒中的炎症小体
  • 批准号:
    10404960
  • 财政年份:
    2020
  • 资助金额:
    $ 23.03万
  • 项目类别:
Targeting Inflammasomes in Substance Abuse and HIV
针对药物滥用和艾滋病毒中的炎症小体
  • 批准号:
    10208845
  • 财政年份:
    2020
  • 资助金额:
    $ 23.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了